Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Jun 6, 2013
Insider Transaction Report
Form 4
Goolsbee William Alden
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2013-06-04+20,000→ 20,000 totalExercise: $34.92From: 2014-06-04Exp: 2023-06-04→ Common Stock (20,000 underlying) - Award
Common Stock
2013-06-04+1,000→ 5,166 total
Footnotes (3)
- [F1]On June 6, 2013, Sarepta Therapeutics, Inc., a Delaware corporation, became the successor of Sarepta Therapeutics, Inc., an Oregon corporation, pursuant to a merger. The merger had the effect of changing the state of incorporation of Sarepta Therapeutics, Inc. from Oregon to Delaware, but did not alter the proportionate interests of security holders.
- [F2]Grant of restricted stock, which shall vest in full on the anniversary date of the grant.
- [F3]This option will vest at a rate of 25% annually over four years beginning on the first anniversary of the date of grant.